536 related articles for article (PubMed ID: 35504134)
1. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.
Wang Y; Chen C; Chen J; Sang T; Peng H; Lin X; Zhao Q; Chen S; Eling T; Wang X
Redox Biol; 2022 Jun; 52():102322. PubMed ID: 35504134
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease.
Xu S; Kong L; Li L; Wang C; Gu J; Luo H; Meng Q
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166930. PubMed ID: 37918680
[TBL] [Abstract][Full Text] [Related]
3. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
[TBL] [Abstract][Full Text] [Related]
4. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
5. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
7. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
8. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
9. HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway.
Ding J; Wu L; Zhu G; Zhu J; Luo P; Li Y
Mol Biol Rep; 2023 Feb; 50(2):961-970. PubMed ID: 36376538
[TBL] [Abstract][Full Text] [Related]
10. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD
Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB
Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499
[TBL] [Abstract][Full Text] [Related]
11. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury
Yi H; Xu D; Wu X; Xu F; Lin L; Zhou H
Antioxid Redox Signal; 2019 Jun; 30(17):1949-1968. PubMed ID: 30484323
[No Abstract] [Full Text] [Related]
12. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
13. Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice.
Li D; Zhang H; Zhong Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):388-394. PubMed ID: 28847729
[TBL] [Abstract][Full Text] [Related]
14.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
15. Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver.
Zhang M; Sun W; Qian J; Tang Y
Redox Biol; 2018 Jun; 16():87-96. PubMed ID: 29482168
[TBL] [Abstract][Full Text] [Related]
16. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
17. NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells.
Chen J; Peng H; Chen C; Wang Y; Sang T; Cai Z; Zhao Q; Chen S; Lin X; Eling T; Wang X
Life Sci; 2022 Dec; 311(Pt A):121142. PubMed ID: 36367498
[TBL] [Abstract][Full Text] [Related]
18. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease.
Xu L; Zhou J; Che J; Wang H; Yang W; Zhou W; Zhao H
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1034-G1044. PubMed ID: 33728991
[TBL] [Abstract][Full Text] [Related]
20. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.
Csak T; Pillai A; Ganz M; Lippai D; Petrasek J; Park JK; Kodys K; Dolganiuc A; Kurt-Jones EA; Szabo G
Liver Int; 2014 Oct; 34(9):1402-13. PubMed ID: 24650018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
